Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices
US-2024252425-A1 · Aug 1, 2024 · US
Multi-chamber cellular mixing and delivery system and method
US9867788B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9867788-B2 |
| Application number | US-201013382703-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 9, 2010 |
| Priority date | Jul 9, 2009 |
| Publication date | Jan 16, 2018 |
| Grant date | Jan 16, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A multi-chamber injection and treatment system includes a first chamber, a second chamber, a mixing element, and a needle portion. The first chamber is generally adapted to receive and advance various cells, while the second chamber is adapted to receive and advance adipose tissue, and can blend or reduce the size of the adipose tissue. The mixing element combines the constituents of the chambers and is in communication with the needle portion for driving the cellular mixture into a target tissue site, such as the mid-corpora of the male penis.
First claim
Opening claim text (preview).
What is claimed is: 1. A multi-chamber mixing and injection system, the system comprising: a first chamber adapted to receive a cellular matter; a second chamber adapted to receive adipose tissue; a tissue reduction element in fluid communication with the second chamber, the tissue reduction element including a blade assembly moveable to produce a reduced adipose tissue and push the reduced adipose tissue distally; an mixing element in fluid communication with a distal outle…
Assignees
Inventors
Classifications
- A61K31/00Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9867788B2 cover?
- A multi-chamber injection and treatment system includes a first chamber, a second chamber, a mixing element, and a needle portion. The first chamber is generally adapted to receive and advance various cells, while the second chamber is adapted to receive and advance adipose tissue, and can blend or reduce the size of the adipose tissue. The mixing element combines the constituents of the chambe…
- Who is the assignee on this patent?
- Schroeder Tania M, Sautner Natalie Ann, Boston Scient Scimed Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/00. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).